Northwell Health

 

Northwell Health
A

Cabozantinib in Patients With Advanced and Progressing Hepatocellular Carcinoma

By Northwell Health FEATURING Anna Levy
By Northwell Health FEATURING Anna Levy
0 views
April 6, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
Oncology & Hematology
17:16
Northwell Health

The Management of HER2+ eBC: Case Discussion and Recent Updates

Feat. F. Esteva
19:34
Northwell Health

Biomarkers in Uveal Melanoma: Considerations for Practice

Feat. S. Khan
08:10
Northwell Health

Antibiotic Prophylaxis for EGFRi-Related Cutaneous Toxicities

Feat. A. Alloo
35:36
Northwell Health

Northwell Health Cancer Institute Fellow Journal Club: Discussing IM…

Feat. N. Seetharamu, A. Hines, S. Patruni
33:08
Northwell Health

Salivary Gland Tumors: Overview of Diagnosis and Management

Feat. A. Hines
11:41
Northwell Health

Neuroendocrine Cancers of the Lung

Feat. N. Seetharamu
19:22
Northwell Health

Current Treatment Landscape in SCLC

Feat. N. Seetharamu
14:12
Northwell Health

Treatment Considerations for Patients With CLL Who Are Elderly or Ha…

Feat. J. Rhodes
07:19
Northwell Health

Cabozantinib in Patients With Advanced and Progressing Hepatocellula…

Feat. A. Levy
14:41
Northwell Health

2021 ASCO Update: Current Advances in CLL

Feat. J. Barrientos